FTSE and growth products are popular as rising volatility makes income products difficult to structure
This webinar looks at the current state of enterprise stress testing and unveils findings of a new study on Enterprise-level Stress Testing (one of several research papers in Chartis' The Risk Enabled Enterprise ® research program)
More Rebecca Hampson articles
ETF provider iShares predicts that ETF investment in Australia will double by 2012 as investors seek more transparency, liquidity and diversification
In flows to gold reached record highs over the last two months as investors move their asset allocation from currencies such as the Euro into physical gold
Deutsche Bank has listed 10 new exchange-traded commodities on the London Stock Exchange to complement the 19 it issued earlier this year in Frankfurt
South Korea launched its new derivatives product approval system in June but issues remain
Citi has added four new hires to its CEEMEA operations as its equity derivatives platform pushes into emerging markets.
The less-than-expected increase in capital gains tax announced by UK chancellor George Osborne means structured products retain their tax-efficient status
The latest Capgemini/Merrill Lynch World Wealth Report predicts greater investment in structured products on the back of a recovery in high-net-worth investors' finances
Growth and income plans were by far the most popular style of product over the past three weeks, thereby disproving the previous UK wrap prediction that autocall products would increase in popularity
Investors continue to buy capital-protected products, but shy away from leverage.
The volumes of retail structured products issued in the UK market have been low over the past few weeks because of volatile markets, although bankers predict autocall products and funds will increase in...
The tax system in the UK has reduced demand for structured products as offshore insurance contracts. “Buying an offshore bond gives investors many tax advantages, but if you include in this personal...
In response to industry fears of a collateral crunch, regulators have revised the proposed rules on margining for uncleared over-the-counter (OTC) derivatives.You can find out more by downloading this white paper here.